Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    April 2017
  1. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Text format     Abstract available


  2. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Text format     Abstract available


    March 2017
  3. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Text format     Abstract available


  4. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Text format     Abstract available


  5. WEISS J, Taron J, Othman AE, Grimm R, et al
    Feasibility of self-gated isotropic radial late-phase MR imaging of the liver.
    Eur Radiol. 2017;27:985-994.
    PubMed     Text format     Abstract available


  6. LI WD, Yu HY, Qian AM, Rong JJ, et al
    Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Eur Radiol. 2017;27:1227-1237.
    PubMed     Text format     Abstract available


  7. LV P, Liu J, Yan X, Chai Y, et al
    CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
    Eur Radiol. 2017;27:918-926.
    PubMed     Text format     Abstract available


  8. SCHMEEL FC, Simon B, Sabet A, Luetkens JA, et al
    Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Eur Radiol. 2017;27:966-975.
    PubMed     Text format     Abstract available


    February 2017
  9. XU Y, Shen Q, Liu P, Xu Z, et al
    Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Eur Radiol. 2017 Feb 10. doi: 10.1007/s00330-017-4740.
    PubMed     Text format     Abstract available


  10. KIM TH, Kim SH, Lee KB, Han JK, et al
    Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
    Eur Radiol. 2017;27:507-517.
    PubMed     Text format     Abstract available


    January 2017
  11. BANNAS P, Bookwalter CA, Ziemlewicz T, Motosugi U, et al
    Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Eur Radiol. 2017;27:32-40.
    PubMed     Text format     Abstract available


  12. VAN DEN HOVEN AF, Braat MN, Prince JF, van Doormaal PJ, et al
    Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.
    Eur Radiol. 2017;27:61-69.
    PubMed     Text format     Abstract available


  13. JAKOBS TF, Paprottka KJ, Raessler F, Strobl F, et al
    Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.
    Eur Radiol. 2017;27:113-119.
    PubMed     Text format     Abstract available


    December 2016
  14. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  15. KIM M, Kang TW, Jeong WK, Kim YK, et al
    Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  16. SOFUE K, Yoshikawa T, Ohno Y, Negi N, et al
    Improved image quality in abdominal CT in patients who underwent treatment for hepatocellular carcinoma with small metal implants using a raw data-based metal artifact reduction algorithm.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  17. VILGRAIN V, Esvan M, Ronot M, Caumont-Prim A, et al
    A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Eur Radiol. 2016;26:4595-4615.
    PubMed     Text format     Abstract available


    November 2016
  18. PICKHARDT PJ, Malecki K, Hunt OF, Beaumont C, et al
    Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  19. ZECH CJ, Justo N, Lang A, Ba-Ssalamah A, et al
    Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Eur Radiol. 2016;26:4121-4130.
    PubMed     Text format     Abstract available


  20. ROUSSET P, Gregory J, Rousset-Jablonski C, Hugon-Rodin J, et al
    MR diagnosis of diaphragmatic endometriosis.
    Eur Radiol. 2016;26:3968-3977.
    PubMed     Text format     Abstract available


    October 2016
  21. AN C, Rhee H, Han K, Choi JY, et al
    Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  22. COSTA AF, Atri M
    Reply to Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  23. RONOT M, Benzimra J, Bouda D, Vilgrain V, et al
    Letter to the Editor re: Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format    


  24. GHOLAMREZANEZHAD A, Mirpour S, Geschwind JF, Rao P, et al
    Evaluation of 70-150-mum doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.
    Eur Radiol. 2016;26:3474-82.
    PubMed     Text format     Abstract available


    September 2016
  25. SUGIHARA F, Murata S, Ueda T, Yasui D, et al
    Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  26. FANG KC, Su CW, Chiou YY, Lee PC, et al
    The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  27. GEEROMS B, Laleman W, Laenen A, Heye S, et al
    Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  28. KIM B, Kim KW, Kim SY, Park SH, et al
    Coronal 2D MR cholangiography overestimates the length of the right hepatic duct in liver transplantation donors.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  29. PARK HJ, Jang KM, Kang TW, Song KD, et al
    Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
    Eur Radiol. 2016;26:3102-11.
    PubMed     Text format     Abstract available


  30. RONOT M, Kerbaol A, Rautou PE, Brancatelli G, et al
    Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.
    Eur Radiol. 2016;26:3094-101.
    PubMed     Text format     Abstract available


  31. FU Y, Peng HJ, Zhang X, Peng WJ, et al
    Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis.
    Eur Radiol. 2016;26:2947-55.
    PubMed     Text format     Abstract available


  32. THAISS WM, Haberland U, Kaufmann S, Spira D, et al
    Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
    Eur Radiol. 2016;26:2929-36.
    PubMed     Text format     Abstract available


    August 2016
  33. LUDWIG JM, Zhang D, Xing M, Kim HS, et al
    Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  34. MIRAGLIA R, Gerasia R, Maruzzelli L, D'Amico M, et al
    Radiation doses to operators performing transjugular intrahepatic portosystemic shunt using a flat-panel detector-based system and ultrasound guidance for portal vein targeting.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  35. HOFFMANN R, Rempp H, Kessler DE, Weiss J, et al
    MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  36. GIRAUDEAU C, Leporq B, Doblas S, Lagadec M, et al
    Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  37. CHOI JW, Kim HC, Lee JH, Yu SJ, et al
    Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  38. HUR S, Chung JW, Zhou CG, Lee JH, et al
    Arteries of the falciform ligament on C-arm CT hepatic arteriography: The hepatic falciform artery and the Sappey's superior artery.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  39. ZHANG W, Chen HJ, Wang ZJ, Huang W, et al
    Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  40. MOCHE M, Heinig S, Garnov N, Fuchs J, et al
    Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients.
    Eur Radiol. 2016;26:2462-70.
    PubMed     Text format     Abstract available


  41. PIEPER CC, Willinek WA, Thomas D, Ahmadzadehfar H, et al
    Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.
    Eur Radiol. 2016;26:2779-89.
    PubMed     Text format     Abstract available


    July 2016
  42. LEE DH, Lee JM, Yi NJ, Lee KW, et al
    Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  43. COSTA AF, Kajal D, Pereira A, Atri M, et al
    Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  44. MONIER A, Guiu B, Duran R, Aho S, et al
    Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  45. FISCHER MA, Marquez HP, Gordic S, Leidner B, et al
    Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  46. KUMAR G, Goldberg SN, Wang Y, Velez E, et al
    Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  47. GORODETSKI B, Chapiro J, Schernthaner R, Duran R, et al
    Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  48. SANO K, Ichikawa T, Motosugi U, Ichikawa S, et al
    Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  49. GROZINGER G, Mann S, Mehra T, Klumpp B, et al
    Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study.
    Eur Radiol. 2016;26:1826-34.
    PubMed     Text format     Abstract available


  50. CHEN SZ, Yuan J, Deng M, Wei J, et al
    Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.
    Eur Radiol. 2016;26:1792-800.
    PubMed     Text format     Abstract available


    May 2016
  51. TAGUCHI N, Oda S, Utsunomiya D, Funama Y, et al
    Using 80 kVp on a 320-row scanner for hepatic multiphasic CT reduces the contrast dose by 50 % in patients at risk for contrast-induced nephropathy.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  52. WIJNANDS TF, Ronot M, Gevers TJ, Benzimra J, et al
    Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  53. FUJITA N, Asayama Y, Nishie A, Ishigami K, et al
    Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  54. GUIU B, Chevallier P, Denys A, Delhom E, et al
    Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  55. KETELSEN D, Groezinger G, Maurer M, Lauer UM, et al
    Three-dimensional C-arm CT-guided transjugular intrahepatic portosystemic shunt placement: Feasibility, technical success and procedural time.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  56. NERI E, Bali MA, Ba-Ssalamah A, Boraschi P, et al
    ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.
    Eur Radiol. 2016;26:921-31.
    PubMed     Text format     Abstract available


  57. HAIMERL M, Schlabeck M, Verloh N, Zeman F, et al
    Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Eur Radiol. 2016;26:1125-33.
    PubMed     Text format     Abstract available


    March 2016
  58. ZHOU CG, Chung JW, Hur S, Lee M, et al
    Sectional Localization of a Small Hepatocellular Carcinoma in the Right Hepatic Lobe by Computed Tomography: Comparison between the Conventional and Portal Vein Tracing Methods.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  59. VAN BINNEBEEK S, Vanbilloen B, Baete K, Terwinghe C, et al
    Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
    Eur Radiol. 2016;26:900-9.
    PubMed     Text format     Abstract available


  60. VOGL TJ, Schaefer P, Lehnert T, Nour-Eldin NE, et al
    Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
    Eur Radiol. 2016;26:755-63.
    PubMed     Text format     Abstract available


  61. MERKLE EM, Zech CJ, Bartolozzi C, Bashir MR, et al
    Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
    Eur Radiol. 2016;26:674-82.
    PubMed     Text format     Abstract available


    February 2016
  62. FISCHER MA, Brehmer K, Svensson A, Aspelin P, et al
    Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  63. HENNEDIGE TP, Hallinan JT, Leung FP, Teo LL, et al
    Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions.
    Eur Radiol. 2016;26:398-406.
    PubMed     Text format     Abstract available


  64. AMBROSETTI MC, Zamboni GA, Mucelli RP
    Distribution of liver metastases based on the site of primary pancreatic carcinoma.
    Eur Radiol. 2016;26:306-10.
    PubMed     Text format     Abstract available


  65. CHRISTOFIDES D, Leen EL, Averkiou MA
    Improvement of the accuracy of liver lesion DCEUS quantification with the use of automatic respiratory gating.
    Eur Radiol. 2016;26:417-24.
    PubMed     Text format     Abstract available


    January 2016
  66. CHEN Y, Li H, Jiang X, Chen D, et al
    Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  67. LV N, Kong Y, Mu L, Pan T, et al
    Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  68. HUANG M, Lin Q, Wang H, Chen J, et al
    Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  69. FETZER DT, Rees MA, Dasyam AK, Tublin ME, et al
    Hepatic sarcoidosis in patients presenting with liver dysfunction: imaging appearance, pathological correlation and disease evolution.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  70. HINRICHS JB, Shin HO, Kaercher D, Hasdemir D, et al
    Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  71. FLECKENSTEIN FN, Schernthaner RE, Duran R, Sohn JH, et al
    3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  72. KANG TW, Rhim H, Lee J, Song KD, et al
    Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  73. HA Y, Lee JB, Shim JH, Kim KM, et al
    Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  74. CHOCKALINGAM A, Duran R, Sohn JH, Schernthaner R, et al
    Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.
    Eur Radiol. 2016;26:103-13.
    PubMed     Text format     Abstract available


  75. WAGNER M, Ronot M, Doblas S, Giraudeau C, et al
    Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
    Eur Radiol. 2016;26:206-15.
    PubMed     Text format     Abstract available


  76. SENDRA L, Perez D, Miguel A, Herrero MJ, et al
    Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.
    Eur Radiol. 2016;26:95-102.
    PubMed     Text format     Abstract available


    December 2015
  77. KIM YS, Song JS, Lee HK, Han YM, et al
    Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  78. LIANG HY, Huang YQ, Yang ZX, Ying-Ding, et al
    Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  79. VESSELLE G, Quirier-Leleu C, Velasco S, Charier F, et al
    Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  80. ZHANG YF, Guo RP, Zou RH, Shen JX, et al
    Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  81. GE M, Zhang J, Wu B, Liu Z, et al
    Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  82. KIM R, Lee JM, Shin CI, Lee ES, et al
    Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  83. YOON JH, Lee JM, Paek M, Han JK, et al
    Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  84. GOUYA H, Grabar S, Vignaux O, Saade A, et al
    Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  85. KIM GM, Kim HC, Hur S, Lee M, et al
    Sloughing of biliary tumour ingrowth of hepatocellular carcinoma after chemoembolization.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  86. HETTERICH H, Bayerl C, Peters A, Heier M, et al
    Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  87. MATOORI S, Froehlich JM, Breitenstein S, Doert A, et al
    Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  88. KERAMIDA G, Dizdarevic S, Bush J, Peters AM, et al
    Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Eur Radiol. 2015;25:2701-8.
    PubMed     Text format     Abstract available


    August 2015
  89. YU MH, Lee JM, Hur BY, Kim TY, et al
    Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Eur Radiol. 2015;25:2428-36.
    PubMed     Text format     Abstract available


  90. WAGNER M, Mariani P, Bidard FC, Rodrigues MJ, et al
    Diffusion-weighted MRI for uveal melanoma liver metastasis detection.
    Eur Radiol. 2015;25:2263-73.
    PubMed     Text format     Abstract available


    July 2015
  91. KIM SH, Kim SH, Kim MA, Shin CI, et al
    CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.
    Eur Radiol. 2015;25:1946-57.
    PubMed     Text format     Abstract available


  92. CHAPIRO J, Duran R, Lin M, Schernthaner R, et al
    Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
    Eur Radiol. 2015;25:1993-2003.
    PubMed     Text format     Abstract available


    June 2015
  93. BOULIN M, Schmitt A, Delhom E, Cercueil JP, et al
    Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  94. KOBAYASHI T, Aikata H, Hatooka M, Morio K, et al
    Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  95. KOH J, Chung YE, Nahm JH, Kim HY, et al
    Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  96. CAI M, Huang W, Lin C, Li Z, et al
    Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  97. FEIER D, Balassy C, Bastati N, Fragner R, et al
    The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  98. ZHANG E, Wartelle-Bladou C, Lepanto L, Lachaine J, et al
    Cost-utility analysis of nonalcoholic steatohepatitis screening.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  99. CHOI SJ, Kim J, Seo J, Kim HS, et al
    Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  100. WU CH, Ho MC, Jeng YM, Liang PC, et al
    Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US.
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


  101. NATTENMULLER J, Hosch W, Nguyen TT, Skornitzke S, et al
    Hypodense liver lesions in patients with hepatic steatosis: do we profit from dual-energy computed tomography?
    Eur Radiol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  102. SUH CH, Kim KW, Kim GY, Shin YM, et al
    The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.
    Eur Radiol. 2015;25:950-60.
    PubMed     Text format     Abstract available


  103. YU J, Liang P, Yu XL, Cheng ZG, et al
    Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours.
    Eur Radiol. 2015;25:1119-26.
    PubMed     Text format     Abstract available


    March 2015
  104. EULER A, Heye T, Kekelidze M, Bongartz G, et al
    Assessment of image quality and low-contrast detectability in abdominal CT of obese patients: comparison of a novel integrated circuit with a conventional discrete circuit detector at different tube voltages.
    Eur Radiol. 2015;25:687-93.
    PubMed     Text format     Abstract available


  105. SHIMADA T, Maruyama H, Kondo T, Sekimoto T, et al
    Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics.
    Eur Radiol. 2015;25:812-20.
    PubMed     Text format     Abstract available


    February 2015
  106. RONOT M, Di Renzo S, Gregoli B, Duran R, et al
    Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.
    Eur Radiol. 2015;25:346-58.
    PubMed     Text format     Abstract available


    January 2015
  107. ABDULLAH BJ, Yeong CH, Goh KL, Yoong BK, et al
    Robotic-assisted thermal ablation of liver tumours.
    Eur Radiol. 2015;25:246-57.
    PubMed     Text format     Abstract available


  108. KOBAYASHI K, Nakao H, Nishiyama T, Lin Y, et al
    Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis.
    Eur Radiol. 2015;25:230-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: